Timo Minssen

Timo Minssen

Professor

ORCID: 0000-0002-3286-4888
31 - 40 out of 63Page size: 10
Sort by: Title

  1. Los secretos comerciales, un obstáculo para la producción de una vacuna contra la Covid-19

    Timo Minssen

    14/08/2020

    1 Media contribution

    Press/Media: Press / Media

  2. Medicinalindustri vil fortsat skjule oplysninger om forsøg

    Timo Minssen

    01/02/2018

    1 Media contribution

    Press/Media: Press / Media

  3. Mixed views on Broad’s fate after EPO revokes CRISPR patent

    Timo Minssen

    18/01/2018

    1 Media contribution

    Press/Media: Press / Media

  4. Novo anklages for patentmisbrug i USA

    Timo Minssen

    21/06/2013

    1 Media contribution

    Press/Media: Press / Media

  5. Novo kaster millioner efter retsopgør med Kåre Schultz og Teva

    Timo Minssen & Karin Beukel

    17/01/2018

    1 Media contribution

    Press/Media: Press / Media

  6. Novo på vej mod sejr i patentstrid

    Timo Minssen

    29/06/2016

    1 Media contribution

    Press/Media: Press / Media

  7. Novo styrer mod overraskende sejr i patentkrig: Berlingske Business

    Timo Minssen

    29/06/2016

    1 Media contribution

    Press/Media: Press / Media

  8. Novo vingeskudt i patentslagsmål: Berlingske Business

    Timo Minssen

    15/03/2016

    1 Media contribution

    Press/Media: Press / Media

  9. Når man blander kunstig intelligens med biomedicin, så er juraen essential - Interview with CeBIL Director Timo Minssen

    Timo Minssen

    11/10/2018

    1 Media contribution

    Press/Media: Press / Media

  10. Obama-forslag truer Novo

    Timo Minssen

    16/02/2011

    1 Media contribution

    Press/Media: Press / Media

Previous 1 2 3 4 5 6 7 Next

ID: 16150437